Home › Trial NCT06864169
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
- Trial IDNCT06864169
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorMerck Sharp & Dohme LLC
- Enrollment160
- Start date2025-04-01
- ConditionsGastrointestinal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.